• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Donor variation in the growth properties and osteogenic potential of human marrow stromal cells.

作者信息

Phinney D G, Kopen G, Righter W, Webster S, Tremain N, Prockop D J

机构信息

Center for Gene Therapy, MCP Hahnemann University, Philadelphia, Pennsylvania 19102, USA.

出版信息

J Cell Biochem. 1999 Dec 1;75(3):424-36.

PMID:10536366
Abstract

Human marrow stromal cells (MSCs) were isolated from posterior illiac crest marrow aspirates obtained from 17 healthy donors, ages 19-45 years, with no apparent physical disability. First passage hMSCs exhibited growth rates in vitro that varied up to 12-fold between donors. No correlation between growth rate and the age or gender of the donor was evident (P </= 0.05). When hMSCs were cultured without passage for eight days (subconfluent cultures) or 22 days (confluent cultures) in the absence of any osteogenic agonists, levels of alkaline phosphatase enzyme activity varied 40-fold and 10-fold, respectively, between donors. When exposed to osteo-inductive media, donor populations also showed dramatic differences in levels of bone-specific gene induction. Collectively, these data demonstrate that hMSC cultures are composed of a heterogeneous mixture of cells at various stages of differentiation and with distinct osteogenic potentials. Differences in both growth rate and ALP activity were evident in hMSC cultures established from multiple aspirates obtained over a six month period from the same donors. Therefore, it appears that cellular heterogeneity produced by the method of harvest is propagated within and among different donor populations during culture expansion in vitro.

摘要

相似文献

1
Donor variation in the growth properties and osteogenic potential of human marrow stromal cells.
J Cell Biochem. 1999 Dec 1;75(3):424-36.
2
Effect of donor characteristics, technique of harvesting and in vitro processing on culturing of human marrow stroma cells for tissue engineered growth of bone.供体特征、采集技术及体外处理对用于骨组织工程生长的人骨髓基质细胞培养的影响
Clin Oral Implants Res. 2005 Oct;16(5):524-31. doi: 10.1111/j.1600-0501.2005.01142.x.
3
Real-time quantitative RT-PCR analysis of human bone marrow stromal cells during osteogenic differentiation in vitro.体外成骨分化过程中人类骨髓基质细胞的实时定量逆转录聚合酶链反应分析
J Cell Biochem. 2002;85(4):737-46. doi: 10.1002/jcb.10174.
4
Donor variation and loss of multipotency during in vitro expansion of human mesenchymal stem cells for bone tissue engineering.用于骨组织工程的人骨髓间充质干细胞体外扩增过程中的供体差异和多能性丧失。
J Orthop Res. 2007 Aug;25(8):1029-41. doi: 10.1002/jor.20402.
5
The influence of proepicardial cells on the osteogenic potential of marrow stromal cells in a three-dimensional tubular scaffold.心外膜前体细胞对三维管状支架中骨髓基质细胞成骨潜能的影响。
Biomaterials. 2008 May;29(14):2203-16. doi: 10.1016/j.biomaterials.2008.01.025. Epub 2008 Mar 4.
6
In vitro and in vivo evaluation of differentially demineralized cancellous bone scaffolds combined with human bone marrow stromal cells for tissue engineering.用于组织工程的差异脱矿松质骨支架与人骨髓基质细胞联合的体外和体内评价
Biomaterials. 2005 Jun;26(16):3173-85. doi: 10.1016/j.biomaterials.2004.08.020.
7
Cellular expression of bone-related proteins during in vitro osteogenesis in rat bone marrow stromal cell cultures.大鼠骨髓基质细胞培养物体外成骨过程中骨相关蛋白的细胞表达
J Cell Physiol. 1994 Mar;158(3):555-72. doi: 10.1002/jcp.1041580322.
8
Maintenance of osteoblastic and adipocytic differentiation potential with age and osteoporosis in human marrow stromal cell cultures.人骨髓基质细胞培养中随着年龄增长和骨质疏松症成骨细胞及脂肪细胞分化潜能的维持。
Calcif Tissue Int. 2002 Jul;71(1):36-44. doi: 10.1007/s00223-001-2059-x. Epub 2002 Jun 24.
9
Donor-to-donor variability in the expansion potential of human bone marrow cells is reduced by accessory cells but not by soluble growth factors.人骨髓细胞扩增潜能的供体间变异性可被辅助细胞降低,但不能被可溶性生长因子降低。
Exp Hematol. 1996 Nov;24(13):1484-93.
10
Platelet-rich concentrate supports human mesenchymal stem cell proliferation, bone morphogenetic protein-2 messenger RNA expression, alkaline phosphatase activity, and bone formation in vitro: a mode of action to enhance bone repair.富血小板浓缩物在体外支持人间充质干细胞增殖、骨形态发生蛋白-2信使核糖核酸表达、碱性磷酸酶活性及骨形成:一种促进骨修复的作用模式。
J Orthop Trauma. 2008 Oct;22(9):595-604. doi: 10.1097/BOT.0b013e318188dbb7.

引用本文的文献

1
Mesenchymal stem cell extracellular vesicle vascularization bioactivity and production yield are responsive to cell culture substrate stiffness.间充质干细胞胞外囊泡的血管生成生物活性及产量对细胞培养底物硬度有反应。
Bioeng Transl Med. 2025 Jan 7;10(3):e10743. doi: 10.1002/btm2.10743. eCollection 2025 May.
2
Electrical Phenotyping of Aged Human Mesenchymal Stem Cells Using Dielectrophoresis.使用介电电泳对衰老的人间充质干细胞进行电表型分析。
Micromachines (Basel). 2025 Apr 3;16(4):435. doi: 10.3390/mi16040435.
3
Human Bone Marrow versus Adipose-Derived Stem Cells: Influence of Donor Characteristics on Expandability and Implications for Osteogenic Ex Vivo BMP-2 Regional Gene Therapy.
人骨髓间充质干细胞与脂肪来源干细胞:供体特征对扩增能力的影响及对骨形态发生蛋白-2体外区域基因治疗成骨作用的意义
J Tissue Eng Regen Med. 2023 Aug 14;2023:8061890. doi: 10.1155/2023/8061890. eCollection 2023.
4
Mesenchymal stem cells and their extracellular vesicle therapy for neurological disorders: traumatic brain injury and beyond.间充质干细胞及其细胞外囊泡治疗神经系统疾病:创伤性脑损伤及其他疾病
Front Neurol. 2025 Feb 5;16:1472679. doi: 10.3389/fneur.2025.1472679. eCollection 2025.
5
3D bioprinted ferret mesenchymal stem cell-laden cartilage grafts for laryngotracheal reconstruction in a ferret surgical model.用于雪貂手术模型喉气管重建的3D生物打印负载雪貂间充质干细胞的软骨移植物
Biomater Sci. 2025 Feb 25;13(5):1304-1322. doi: 10.1039/d4bm01251h.
6
Biopotency and surrogate assays to validate the immunomodulatory potency of extracellular vesicles derived from mesenchymal stem/stromal cells for the treatment of experimental autoimmune uveitis.鉴定间充质干细胞来源的细胞外囊泡的免疫调节效力的生物效价和替代测定法,用于治疗实验性自身免疫性葡萄膜炎。
J Extracell Vesicles. 2024 Aug;13(8):e12497. doi: 10.1002/jev2.12497.
7
Advantages of pooling of human bone marrow-derived mesenchymal stromal cells from different donors versus single-donor MSCs.从不同供体中汇集人骨髓间充质基质细胞与使用单供体 MSC 的优势。
Sci Rep. 2024 Jun 2;14(1):12654. doi: 10.1038/s41598-024-62544-8.
8
Single-cell sequencing advances in research on mesenchymal stem/stromal cells.单细胞测序技术在间充质干细胞研究中的进展。
Hum Cell. 2024 Jul;37(4):904-916. doi: 10.1007/s13577-024-01076-9. Epub 2024 May 14.
9
High throughput screening of mesenchymal stromal cell morphological response to inflammatory signals for bioreactor-based manufacturing of extracellular vesicles that modulate microglia.基于生物反应器制造可调节小胶质细胞的细胞外囊泡,对间充质基质细胞对炎症信号的形态学反应进行高通量筛选。
Bioact Mater. 2024 Mar 20;37:153-171. doi: 10.1016/j.bioactmat.2024.03.009. eCollection 2024 Jul.
10
An Overview of Mesenchymal Stem Cell Heterogeneity and Concentration.间充质干细胞的异质性与浓度概述
Pharmaceuticals (Basel). 2024 Mar 7;17(3):350. doi: 10.3390/ph17030350.